» Articles » PMID: 34493762

Dynamics of SARS-CoV-2 Mutations Reveals Regional-specificity and Similar Trends of N501 and High-frequency Mutation N501Y in Different Levels of Control Measures

Abstract

Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease has spread globally, causing more than 161.5 million cases and 3.3 million deaths to date. Surveillance and monitoring of new mutations in the virus' genome are crucial to our understanding of the adaptation of SARS-CoV-2. Moreover, how the temporal dynamics of these mutations is influenced by control measures and non-pharmaceutical interventions (NPIs) is poorly understood. Using 1,058,020 SARS-CoV-2 from sequenced COVID-19 cases from 98 countries (totaling 714 country-month combinations), we perform a normalization by COVID-19 cases to calculate the relative frequency of SARS-CoV-2 mutations and explore their dynamics over time. We found 115 mutations estimated to be present in more than 3% of global COVID-19 cases and determined three types of mutation dynamics: high-frequency, medium-frequency, and low-frequency. Classification of mutations based on temporal dynamics enable us to examine viral adaptation and evaluate the effects of implemented control measures in virus evolution during the pandemic. We showed that medium-frequency mutations are characterized by high prevalence in specific regions and/or in constant competition with other mutations in several regions. Finally, taking N501Y mutation as representative of high-frequency mutations, we showed that level of control measure stringency negatively correlates with the effective reproduction number of SARS-CoV-2 with high-frequency or not-high-frequency and both follows similar trends in different levels of stringency.

Citing Articles

The RdRp genotyping of SARS-CoV-2 isolated from patients with different clinical spectrum of COVID-19.

Majchrzak M, Madej L, Lysek-Gladysinska M, Zarebska-Michaluk D, Zegadlo K, Dziuba A BMC Infect Dis. 2024; 24(1):281.

PMID: 38439047 PMC: 10913261. DOI: 10.1186/s12879-024-09146-x.


Real-time evaluation of signal accuracy in wastewater surveillance of pathogens with high rates of mutation.

Thakali O, Mercier E, Eid W, Wellman M, Brasset-Gorny J, Overton A Sci Rep. 2024; 14(1):3728.

PMID: 38355869 PMC: 10866965. DOI: 10.1038/s41598-024-54319-y.


Temporal Dynamics and Genomic Landscape of SARS-CoV-2 After Four Years of Evolution.

Essabbar A, El Mazouri S, Boumajdi N, Bendani H, Aanniz T, Mouna O Cureus. 2024; 16(2):e53654.

PMID: 38327721 PMC: 10849819. DOI: 10.7759/cureus.53654.


Identifying Innate Resistance Hotspots for SARS-CoV-2 Antivirals Using In Silico Protein Techniques.

Portelli S, Heaton R, Ascher D Genes (Basel). 2023; 14(9).

PMID: 37761839 PMC: 10531314. DOI: 10.3390/genes14091699.


Delivery of biologics: Topical administration.

Kulchar R, Singh R, Ding S, Alexander E, Leong K, Daniell H Biomaterials. 2023; 302:122312.

PMID: 37690380 PMC: 10840840. DOI: 10.1016/j.biomaterials.2023.122312.


References
1.
Dejnirattisai W, Zhou D, Supasa P, Liu C, Mentzer A, Ginn H . Antibody evasion by the P.1 strain of SARS-CoV-2. Cell. 2021; 184(11):2939-2954.e9. PMC: 8008340. DOI: 10.1016/j.cell.2021.03.055. View

2.
Biswas S, Mudi S . Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19. Genomics Inform. 2021; 18(4):e44. PMC: 7808873. DOI: 10.5808/GI.2020.18.4.e44. View

3.
Callaway E . The coronavirus is mutating - does it matter?. Nature. 2020; 585(7824):174-177. DOI: 10.1038/d41586-020-02544-6. View

4.
Hyafil A, Morina D . Analysis of the impact of lockdown on the reproduction number of the SARS-Cov-2 in Spain. Gac Sanit. 2020; 35(5):453-458. PMC: 7245209. DOI: 10.1016/j.gaceta.2020.05.003. View

5.
Rozen D, Lenski R . Long-Term Experimental Evolution in Escherichia coli. VIII. Dynamics of a Balanced Polymorphism. Am Nat. 2000; 155(1):24-35. DOI: 10.1086/303299. View